OFFICIAL PUBLICATION OF

by its subsidiary APPco

Pricing overhaul

Chris Brooker 22/06/2017

Dispensing fees, pricing discretion and pharmacy layout in the King Review firing line Pharmacies should have no discretion to either raise or lower prices for PBS-listed medicines beyond the co-payment set by the government or the dispensed price, the Review of Pharmacy Remuneration and Regulation has recommended. The interim report of the Review of Pharmacy

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘We need more pharmacists’

Could start with ensuring the owner at least lives in the STATE of the pharmacy he owns , first

geoffrey colledge

‘We need more pharmacists’

My view of the problem is a fault lying with the universities. There are mainly overseas students and predominantly female…

geoffrey colledge

‘Doctor of Pharmacy’ title announced

Dentists don't don't do a Masters to get the title, they do a Batchelor of Dental Surgery. I'm also pretty…

Red Dog

‘Doctor of Pharmacy’ title announced

Difference is a dentist does a Batchelor of Dental Surgery, and therefore are a Doctor

Red Dog

Pricing overhaul

Previous King Review option treats pharmacy like 'utility company'

Next New PSA National President to tackle recognition, remuneration

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous King Review option treats pharmacy like 'utility company'

Next New PSA National President to tackle recognition, remuneration

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.